AMETEK Q3 sales rise 11%, beat expectations

Reuters
2025/10/30
AMETEK Q3 sales rise 11%, beat expectations

Overview

  • AMETEK Q3 sales rise 11% yr/yr to $1.89 bln, beating analyst expectations

  • Adjusted EPS for Q3 increases 14% yr/yr, beating consensus

  • Company raises full-year adjusted EPS guidance to $7.32-$7.37

Outlook

  • AMETEK raises full-year adjusted EPS guidance to $7.32-$7.37

  • Company expects Q4 sales to rise 10% year-over-year

  • Company anticipates Q4 adjusted EPS of $1.90-$1.95

Result Drivers

  • EIG SALES GROWTH - EIG sales increased 10% yr/yr, contributing to margin expansion

  • EMG SALES GROWTH - EMG sales rose 13% yr/yr, leading to record operating income and margin expansion

  • FARO INTEGRATION - Progress in FARO Technologies integration seen as positive for future growth

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Beat

$1.89 bln

$1.82 bln (11 Analysts)

Q3 Adjusted EPS

Beat

$1.89

$1.76 (14 Analysts)

Q3 EPS

$1.60

Q3 Net Income

$371.41 mln

Q3 Basic EPS

$1.61

Q3 Operating income

$488.38 mln

Q3 Pretax Profit

$447.96 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 8 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the electrical components & equipment peer group is "buy"

  • Wall Street's median 12-month price target for AMETEK Inc is $211.00, about 12.7% above its October 29 closing price of $184.19

  • The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 25 three months ago

Press Release: ID:nPn3fkDr7a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10